Cystatin C is associated with adverse COVID-19 outcomes in diverse populations

Kleeman, Sam O, Cordioli, Mattia, Timmers, Paul RHJ, Khan, Atlas, Tober-Lau, Pinkus, Kurth, Florian, Demichev, Vadim, Meyer, Hannah V, Wilson, James F, Ralser, Markus, Kiryluk, Krzysztof, Ganna, Andrea, Baillie, Kenneth, Janowitz, Tobias (October 2022) Cystatin C is associated with adverse COVID-19 outcomes in diverse populations. iScience, 25 (10). p. 105040. ISSN 2589-0042 (In Press)

[thumbnail of 2022-Janowitz-Cystatin-C-is-associated-with-adverse-covid-19-outcomes-in-diverse-populations.pdf] PDF
2022-Janowitz-Cystatin-C-is-associated-with-adverse-covid-19-outcomes-in-diverse-populations.pdf
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB)
DOI: 10.1016/j.isci.2022.105040
Item Type: Paper
Subjects: diseases & disorders > viral diseases > coronavirus > covid 19
CSHL Authors:
Communities: CSHL labs > Janowitz lab
CSHL labs > Meyer Lab
SWORD Depositor: CSHL Elements
Depositing User: CSHL Elements
Date: October 2022
Date Deposited: 15 Sep 2022 21:23
Last Modified: 10 Oct 2022 14:03
PMCID: PMC9428108
URI: https://repository.cshl.edu/id/eprint/40719

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving